In addition to the role of SDF-1/CXCR7 as a chemokine, our data provide evidence of its ability to limit the expansion of adipose tissue, which further highlights its therapeutic potential in obesity-related metabolic disorders. This evidence concerns the gene ACKR3 and Other metabolic disease.